112 related articles for article (PubMed ID: 10958895)
1. Effects of the second-generation leukotriene B(4) receptor antagonist, LY293111Na, on leukocyte infiltration and collagen-induced arthritis in mice.
Kuwabara K; Yasui K; Jyoyama H; Maruyama T; Fleisch JH; Hori Y
Eur J Pharmacol; 2000 Aug; 402(3):275-85. PubMed ID: 10958895
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of antigen-induced arthritis in guinea pigs by a selective LTB4 receptor antagonist LY293111Na.
Kuwabara K; Jyoyama H; Fleisch JH; Hori Y
Inflamm Res; 2002 Nov; 51(11):541-50. PubMed ID: 12540018
[TBL] [Abstract][Full Text] [Related]
3. Effects of leukotriene B4 receptor antagonist, LY293111Na, on antigen-induced bronchial hyperresponsiveness and leukocyte infiltration in sensitized guinea pigs.
Asanuma F; Kuwabara K; Arimura A; Furue Y; Fleisch JH; Hori Y
Inflamm Res; 2001 Mar; 50(3):136-41. PubMed ID: 11339501
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic actions of the second generation leukotriene B4 receptor antagonist LY29311: in vivo pulmonary studies.
Silbaugh SA; Stengel PW; Cockerham SL; Froelich LL; Bendele AM; Spaethe SM; Sofia MJ; Sawyer JS; Jackson WT
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):397-404. PubMed ID: 10763854
[TBL] [Abstract][Full Text] [Related]
5. IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4.
Canetti CA; Leung BP; Culshaw S; McInnes IB; Cunha FQ; Liew FY
J Immunol; 2003 Jul; 171(2):1009-15. PubMed ID: 12847274
[TBL] [Abstract][Full Text] [Related]
6. Involvement of leukotriene B(4) in substance P-induced itch-associated response in mice.
Andoh T; Katsube N; Maruyama M; Kuraishi Y
J Invest Dermatol; 2001 Dec; 117(6):1621-6. PubMed ID: 11886531
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiological role of mast cells in collagen-induced arthritis: study with a cysteinyl leukotriene receptor antagonist, montelukast.
Shiota N; Shimoura K; Okunishi H
Eur J Pharmacol; 2006 Oct; 548(1-3):158-66. PubMed ID: 16949072
[TBL] [Abstract][Full Text] [Related]
8. Reversal of human neutrophil survival by leukotriene B(4) receptor blockade and 5-lipoxygenase and 5-lipoxygenase activating protein inhibitors.
Lee E; Lindo T; Jackson N; Meng-Choong L; Reynolds P; Hill A; Haswell M; Jackson S; Kilfeather S
Am J Respir Crit Care Med; 1999 Dec; 160(6):2079-85. PubMed ID: 10588632
[TBL] [Abstract][Full Text] [Related]
9. The effect of leukotriene synthesis inhibitors in models of acute and chronic inflammation.
Nickerson-Nutter CL; Medvedeff ED
Arthritis Rheum; 1996 Mar; 39(3):515-21. PubMed ID: 8607901
[TBL] [Abstract][Full Text] [Related]
10. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
11. The effects of LY293111Na, a leukotriene B4 receptor antagonist, on the pulmonary neutrophilia and CD11b expression caused by inhalation of a leukotriene B4 aerosol in rhesus monkeys.
Allen DL; Hoffman WP; Marder P; Matchett MR; Leiter PA; Abbott DL; Wolff RK
J Pharmacol Exp Ther; 1996 Apr; 277(1):341-9. PubMed ID: 8613940
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis.
Griffiths RJ; Pettipher ER; Koch K; Farrell CA; Breslow R; Conklyn MJ; Smith MA; Hackman BC; Wimberly DJ; Milici AJ
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):517-21. PubMed ID: 7831322
[TBL] [Abstract][Full Text] [Related]
13. Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5- hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist.
Marder P; Sawyer JS; Froelich LL; Mann LL; Spaethe SM
Biochem Pharmacol; 1995 May; 49(11):1683-90. PubMed ID: 7786309
[TBL] [Abstract][Full Text] [Related]
14. Intradermal leukotriene B4, but not prostaglandin E2, induces itch-associated responses in mice.
Andoh T; Kuraishi Y
Eur J Pharmacol; 1998 Jul; 353(1):93-6. PubMed ID: 9721045
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory activity of a potent, selective leukotriene A4 hydrolase inhibitor in comparison with the 5-lipoxygenase inhibitor zileuton.
Rao NL; Dunford PJ; Xue X; Jiang X; Lundeen KA; Coles F; Riley JP; Williams KN; Grice CA; Edwards JP; Karlsson L; Fourie AM
J Pharmacol Exp Ther; 2007 Jun; 321(3):1154-60. PubMed ID: 17371808
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene B(4) receptors BLT1 and BLT2 are involved in interleukin-8 production in human neutrophils induced by Trichomonas vaginalis-derived secretory products.
Nam YH; Min A; Kim SH; Lee YA; Kim KA; Song KJ; Shin MH
Inflamm Res; 2012 Feb; 61(2):97-102. PubMed ID: 22215047
[TBL] [Abstract][Full Text] [Related]
17. Phorbol ester-induced dermal inflammation in mice: evaluation of inhibitors of 5-lipoxygenase and antagonists of leukotriene B4 receptor.
Rao TS; Yu SS; Djuric SW; Isakson PC
J Lipid Mediat Cell Signal; 1994 Sep; 10(3):213-28. PubMed ID: 7812673
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Leukotriene B4 Released from Keratinocytes in Itch-associated Response to Intradermal Interleukin-31 in Mice.
Andoh T; Harada A; Kuraishi Y
Acta Derm Venereol; 2017 Aug; 97(8):922-927. PubMed ID: 28512667
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice.
Rainsford KD
J Pharm Pharmacol; 1999 Mar; 51(3):331-9. PubMed ID: 10344635
[TBL] [Abstract][Full Text] [Related]
20. Combination therapies that inhibit cyclooxygenase-2 and leukotriene synthesis prevent disease in murine collagen induced arthritis.
Anderson GD; Keys KL; De Ciechi PA; Masferrer JL
Inflamm Res; 2009 Feb; 58(2):109-17. PubMed ID: 19184362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
